Disclosures:
All relevant financial relationships with ineligible companies listed for these individuals have been mitigated:
Faculty:
– Rason Hunter, CCHT—Employee:  Fresenius
Planners:
– Kristina Bryant, MD—Research Funding: Gilead and Enanta
– Dana Mitchell, MD, FASN—Speaker’s Bureau and Honoraria: Astra Zeneca and Mallinckrodt
No other planners or faculty for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.